Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice.
Heinzerling L, Kühnapfel S, Meckbach D, Baiter M, Kaempgen E, Keikavoussi P, Schuler G, Agaimy A, Bauer J, Hartmann A, Kiesewetter F, Schneider-Stock R.
Heinzerling L, et al. Among authors: agaimy a.
Br J Cancer. 2013 May 28;108(10):2164-71. doi: 10.1038/bjc.2013.143. Epub 2013 Apr 11.
Br J Cancer. 2013.
PMID: 23579220
Free PMC article.